Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …
Germany/Chair: Hello, welcome to our discussion regarding the way forward in advancing the implementation of all international drug policy commitments in light of the 2029 finally view of certain 2019 Ministerial Declaration in accordance with CND Resolution 66 Adopted by the Commission last March, this roundtable will consist of panel interventions followed by an interactive …
UN Web TV recording ;Bangladesh/Chair: Discuss the work done around the globe to implement drug control commitments – identify progress, identify challenges. This will consist of a panel of interventions followed by interactive discussions. Mexico/Co-Chair: Delegations wishing to take the floor can raise their panels to nominate themselves. Please bear with me if I call …
UN Web TV recording Opening of the 67th session of the Commission on Narcotic DrugsOutcome Document: High-level Declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the 2019 Ministerial DeclarationChair: Welcome. Inform you that for the opening session of the HLS, there’ll be a video transmission of the …
Chair: Good Morning. The focus of our discussion pertains to Strategic Management budgetary and administrative motions in the context of our economy. Yesterday, in collaboration with the CCP CJ, we deliberated on the Consolidated budget for the biennium 2024-2025 for the United Nations Office on Drugs and Crime, referencing Containers document 5.2 (2013) and 15/2017, …
Chair: I am grateful for your cooperation earlier this year. We had previously discussed the Resolution, outlining the review process, and collectively decided to convene before he regular committee session. The high-level segment is scheduled for March 14th and 15th, dedicated to assessing the implementation of international drug policy commitments. During this segment, we aim …